Conformable Osteochondral Repair Platforms for Prevention of Post Traumatic Osteoarthritis
Award amount
$1,149,031Program and phase
SBIR · Phase IIAward year
2020Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- Theradaptive
- Proposal award date
- 2020-06-15
- Contract end date
- 2022-10-20
- UEI
- DN45N68LM8M6
- Solicitation number
- 17.1
- Topic code
- DHA17-009
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler
- BioloGel - Building Blocks for Osteochondral Regeneration
- BioloGel - Building Blocks for Osteochondral Regeneration
- Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler
Research funding history
2 SBIR/STTR records share this UEI (2017–2020). Reported award amounts total $1,299,030. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense